
Written based on 15 research studies on PubMed, searched on 11 Nov 2026.
The claim
Posts say high-dose vitamin C given through a drip can help people with glioblastoma, an aggressive brain tumour.
Where research stands
We found 35 published papers on vitamin C (incl. high-dose) and glioblastoma. They were published between 1969 and 2026. 3 of them are studies in people. At least 55 people took part. None of them compared people who got it with a group that did not. 5 were studies in animals, and 19 were only in cells in the lab. 1 paper is a review that sums up other studies. 2 new studies in people are running or will start soon, say the trial registers.
- 3In people
- 5In animals
- 19Only in the lab
What the studies found
Trials in people
A small first test in people, mainly to check safety, added high-dose vitamin C to standard treatment. [1] 11 people could be evaluated, and the authors report no dose-limiting side effects. [1] A later trial with 55 people had no comparison group treated at the same time. [2] People in it lived a median of 19.6 months, against 14.6 months in older studies. [2] Neither trial compared people with a group that did not get vitamin C, so this does not show vitamin C caused the difference. [1][2]
Other studies in people
One report looked at iron-related markers in tumours of the 55 people and how long they lived. [3] Another study of 37 tumour samples linked more vitamin C in the tumour to longer survival. [4] Such a link does not show cause. [4]
Reviews
A 2021 review said high-dose vitamin C looks safe and may help in several cancers. [5] It said larger studies comparing with a group not getting it are needed. [5]
In animals
In mice, vitamin C with another treatment slowed human glioblastoma tumours more than either alone. [6] In rats, high doses of vitamin C slowed tumour growth and spread. [8] One study in guinea pigs suggested vitamin C may help the tumour progress instead. [9] Results in animals do not always hold in people.
In the lab
In cell studies, high-dose vitamin C killed glioblastoma cells, and added iron made this stronger. [10][11] Some types of glioblastoma cells were less affected than others. [13]
Verdict
Two small trials in people had good results, but neither compared with a group not getting vitamin C. [1][2] Results in animals and cells are mixed but promising. [6][8][9][10][11] Nothing yet confirms it helps people, so the claim is partly true. [5]
Partly true means: people did well, but no fair test with a comparison group has shown it yet. Or only part of the claim holds. How we rate claims
What this means for you: A study in people is not proof that it helps you. Do not stop or change your medicines because of it. Ask your doctor before you start taking it.
Sources
- First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed Glioblastoma.2019 · Clin Cancer Res · Study in people
- Magnetic Resonance Imaging of Iron Metabolism with T2* Mapping Predicts an Enhanced Clinical Response to Pharmacologic Ascorbate in Patients with GBM.2024 · Clin Cancer Res · Study in people
- Iron-based biomarkers for personalizing pharmacological ascorbate therapy in glioblastoma: insights from a phase 2 clinical trial.2024 · J Neurooncol · Other paper
- Increased Ascorbate Content of Glioblastoma Is Associated With a Suppressed Hypoxic Response and Improved Patient Survival.2022 · Front Oncol · Other paper
- Parenteral high‑dose ascorbate - A possible approach for the treatment of glioblastoma (Review).2021 · Int J Oncol · Review
- Combined effects of vitamin C and cold atmospheric plasma-conditioned media against glioblastoma via hydrogen peroxide.2023 · Free Radic Biol Med · In animals
- Selenium Modulates Cancer Cell Response to Pharmacologic Ascorbate.2022 · Cancer Res · In animals
- High doses of sodium ascorbate interfere with the expansion of glioblastoma multiforme cells in vitro and in vivo.2019 · Life Sci · In animals
- Glioblastoma Invasiveness and Collagen Secretion Are Enhanced by Vitamin C.2022 · Antioxid Redox Signal · In animals
- Analysis of High-Dose Ascorbate-Induced Cytotoxicity in Human Glioblastoma Cells and the Role of Dehydroascorbic Acid and Iron.2024 · Antioxidants (Basel) · In animals
- Targeting glioblastoma multiforme cells with pharmacological ascorbate: Disrupting DNA damage response and mTOR cascades via extracellular H2O2.2025 · Free Radic Biol Med · In the lab
- Pharmacological Ascorbate Restrains Epithelial-Mesenchymal Transition and Invasion in Glioblastoma Cells via Extracellular H2O2 Generation.2026 · Int J Mol Sci · In the lab
- Differential H2O2 Metabolism among Glioblastoma Subtypes Confers Variable Responses to Pharmacological Ascorbate Therapy Combined with Chemoradiation.2023 · Int J Mol Sci · Other paper
- Selenium supplementation protects cancer cells from the oxidative stress and cytotoxicity induced by the combination of ascorbate and menadione sodium bisulfite.2025 · Free Radic Biol Med · In the lab
- Combination of Ascorbic Acid and Menadione Induces Cytotoxic Autophagy in Human Glioblastoma Cells.2022 · Oxid Med Cell Longev · Other paper



